Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

TAVR-related ischemic stroke linked to worse outcomes, higher Medicare costs

TAVR-related stroke, the authors wrote, is a "critically important and potentially preventable source of patient morbidity."

Thumbnail

'Highly significant' MRI findings link hyperthyroidism to structural brain abnormalities

“For decades, the patients in our group have testified that they don’t feel they’ve recovered, and we hope our study will provide further clues about what happens in the brain,” experts involved in the study said.

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

An example of the CV Wizard clinical decision support (CDS) software showing a screen designed to help patients better understand their risks and areas they need to work on. It is graphically based to enable patients who have a lower level of literacy better understand their cardiovascular risks, rather than using a long text report.

Clinical decision support may improve cardiac care at low-income community health centers

Evidence shows this technology has the potential to improve care for vulnerable patients with cardiovascular disease.

Thumbnail

Mammograms should not be delayed after COVID vaccine, research shows

Reactive axillary lymph nodes seen on screening mammograms after vaccination can last for many months and should not be cause for imaging delays, experts reported in Radiology.

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

Thumbnail

AHIP urges Congress to curtail price gouging on COVID-19 tests: ‘The problem has gotten worse’

In some cases, out-of-network providers charged $185 for a test that costs $130, on average, America’s Health Insurance Plans stated in a recent letter.